Momordica charantia subsp. charantia
Momordica charantia subsp. charantia · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Momordica charantia subsp. charantia, commonly known as bitter melon, is a versatile plant renowned for its significant medicinal properties. Scientific research highlights its potent ability to combat oxidative stress through high antioxidant activity. This subspecies is particularly noted for its therapeutic potential in managing dyslipidemia by regulating lipid levels in the blood. Furthermore, it plays a crucial role in metabolic health by helping to mitigate postprandial hyperglycemia after meals. Consequently, this plant serves as a vital natural resource for addressing various metabolic challenges.
- Synonyms
- Momordica Anthelmintica · Momordica Zeylanica · 22 more
- Common names
- Not available
- Family
- Cucurbitaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Common Names
Momordica charantia subsp. charantia is a versatile plant known by a diverse array of regional names. It is frequently referred to as Balsampear or Balzsamkörte depending on the linguistic context. In many areas, it is widely recognized by the common name Bittermelone. Some enthusiasts also call it Cundeamor, a name that highlights its unique botanical character. Additionally, it is often identified as the Wild balsam apple, showcasing its wild and resilient nature.
Sources: Catalogue of Life (COL)
Synonyms
Momordica charantia subsp. charantia is a taxonomically complex plant that is associated with several different botanical names. Within various scientific records, it is recognized by the synonym Cucumis argyi and also as Cucumis intermedius. The subspecies is further linked to Momordica anthelmintica in certain biological classifications. Additionally, researchers have identified specific forms such as Momordica charantia f. abbreviata. Finally, the plant is also synonymous with the formal designation Momordica charantia f. muricata.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Momordica charantia subsp. charantia belongs to the vast kingdom Plantae, representing a diverse lineage of life. Within this kingdom, it is classified under the class Equisetopsida, marking its place among the vascular plants. It further descends through the order Cucurbitales, which connects it to many other significant botanical groups. This specific plant is a member of the genus Momordica, a group known for its unique characteristics. Finally, it finds its botanical home within the family Cucurbitaceae, alongside other well-known gourds and melons.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Cucurbitales |
| Family | Cucurbitaceae |
| Genus | Momordica |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Momordica charantia subsp. charantia exhibits a diverse geographic range spanning several key regions across the African continent. Within East Tropical Africa, this specific subspecies is widely distributed through the territories of Kenya, Tanzania, and Uganda. Its presence extends beyond the mainland to include the Macaronesia region, specifically inhabiting the Canary Islands. Additionally, the plant can be found growing in the island nation of Cape Verde. This widespread distribution highlights the plant's ability to thrive in various tropical and Atlantic environments.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Biological Activities
Compounds
Conditions
Momordica charantia subsp. charantia treats diabetes by inhibiting enzymes like α-amylase and α-glucosidase to manage postprandial hyperglycemia. The protein extracts from this plant also treat anti-lipidemic and antioxidant concerns by reducing cholesterol levels and increasing protective enzymes in diabetic models. Scientific evidence shows that the plant effectively treats blood glucose level spikes following carbohydrate consumption. Furthermore, its administration successfully treats area under the curve metrics, demonstrating a significant reduction in glycemic response. Together, these therapeutic properties support its traditional use in managing the various complications associated with type 2 diabetes.